Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies.
about
Metadherin interference inhibits proliferation and enhances chemo-sensitivity to doxorubicin in diffuse large B cell lymphoma.Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP.Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapyClear cell variant of diffuse large B-cell lymphoma: a case report.HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCLALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway.NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia.Prognostic value of expression of nuclear factor kappa-B/p65 in non-GCB DLBCL patients.Expression and pro-survival function of phospholipase Cγ2 in diffuse large B-cell lymphoma.MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen.Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1.Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma.
P2860
Q34167090-FFE30B1A-EE6D-4E63-8F2B-3A395418EE04Q34302472-78990984-7C06-4F93-80F8-42EB31466565Q34451400-909765B7-BF6C-436F-A2F2-A4D543E6DF9DQ35053072-F9E7C0E7-637F-42AD-8EEE-BBD3A4D09483Q35553330-745AE564-0D06-443D-A3E2-B9D92CA860FCQ37229779-21B22E2D-B93D-47EB-8957-E0E15D1DB6DEQ37605861-8AF9269A-6BB7-4B9B-AC96-CED787B390A3Q37706051-C2F335C9-05DE-4BAE-A8BB-BD32E11BBE99Q38976449-CF78769A-08C6-4D50-9656-1D181416A782Q39218802-140771CB-09C7-4940-9C16-36D9699EB170Q39407871-23458238-2A51-403D-8833-B038FE6ED435Q42355782-95148787-AC62-4255-9283-4E6D4EBE60BB
P2860
Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Recent prognostic factors in d ...... or new therapeutic strategies.
@en
Recent prognostic factors in d ...... or new therapeutic strategies.
@nl
type
label
Recent prognostic factors in d ...... or new therapeutic strategies.
@en
Recent prognostic factors in d ...... or new therapeutic strategies.
@nl
prefLabel
Recent prognostic factors in d ...... or new therapeutic strategies.
@en
Recent prognostic factors in d ...... or new therapeutic strategies.
@nl
P2860
P50
P1433
P1476
Recent prognostic factors in d ...... for new therapeutic strategies
@en
P2093
Alessandro Pavan
Silvia Sansonno
P2860
P304
P356
10.1080/10428190802444176
P577
2008-11-01T00:00:00Z